-
Mashup Score: 0Moving From Crisis To Lasting Change - 4 year(s) ago
Our industry has an opportunity — an obligation really — to harness and improve upon the efforts made over the last few months to formalize a new operating model utilizing all of the clinical, digital, and pharmacological tools at our disposal to raise the standard of care for people well into the future.
Source: www.lifescienceleader.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Building GSK Oncology R&D - 4 year(s) ago
Axel Hoos, M.D., Ph.D., SVP oncology and R&D governance chair, provides an update and the context of GSK’s R&D strategy.
Source: www.lifescienceleader.comCategories: Hem/Oncs, Latest HeadlinesTweet-
The power of #leadership @GSK “We added 75 percent to the nonclinical portfolio from 2016 to today,” Hoos states. “ the clinical pipeline has matured by 320 percent.” From five assets in the clinic in 2016, GSK now boasts having 16. Dr. Axel Hoos https://t.co/zl3ebMNlwQ https://t.co/J176SxJb2e
-
-
Mashup Score: 0
Here, we discuss the emergence of AI healthcare technologies, the intersectionality between AI healthcare technologies and product liability, and…
Source: www.lifescienceleader.comCategories: Future of MedicineTweet-
#Opinion The Inevitable Collision of #AI #Healthcare Technologies And Product #Liability https://t.co/XHJI9MZjp1
-
-
Mashup Score: 3Why John Sculley Views Healthcare As His "Noble Cause" - 4 year(s) ago
John Sculley, the former CEO of Apple who is now an entrepreneur and investor in high-tech startups, discusses where he sees opportunity in the…
Source: www.lifescienceleader.comCategories: Future of MedicineTweet-
RT @CNSSummit: @CNSSummit keynote speaker John Sculley discusses why healthcare is his "noble cause" https://t.co/sbkHD0vAKL https://t.co/…
-
-
Mashup Score: 3Why John Sculley Views Healthcare As His "Noble Cause" - 4 year(s) ago
John Sculley, the former CEO of Apple who is now an entrepreneur and investor in high-tech startups, discusses where he sees opportunity in the…
Source: www.lifescienceleader.comCategories: Healthcare ProfessionalsTweet-
RT @JohnNosta: Fascinating! Why John Sculley Views Healthcare As His "Noble Cause" https://t.co/cpQ9BlmvcI @RfwrightLSL @johnsculley #healt…
-
-
Mashup Score: 3Why John Sculley Views Healthcare As His "Noble Cause" - 4 year(s) ago
John Sculley, the former CEO of Apple who is now an entrepreneur and investor in high-tech startups, discusses where he sees opportunity in the…
Source: www.lifescienceleader.comCategories: Future of MedicineTweet-
Fascinating! Why John Sculley Views Healthcare As His "Noble Cause" https://t.co/cpQ9BlmvcI @RfwrightLSL @johnsculley #healthcare #digitalhealth @celularity @HaririRobert
-
-
Mashup Score: 3
David Chang, M.D., Ph.D., founder and CEO of Allogene Therapeutics, along with numerous other physicians have opted to become biopharmaceutical…
Source: www.lifescienceleader.comCategories: Future of MedicineTweet-
RT @RfwrightLSL: Why Top Researchers And Physicians Enter The World Of Biopharma R&D https://t.co/aPPukAStHi #JPM20 @Pfizer @AllogeneTx @Ha…
-
Moving From Crisis To Lasting Change https://t.co/bzQBZbsxg9